Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1957 1
1962 1
1963 1
1964 1
1965 1
1966 1
1967 3
1968 7
1969 2
1970 4
1971 1
1972 3
1973 6
1974 6
1975 9
1976 6
1977 4
1978 6
1979 7
1980 6
1981 3
1982 7
1983 9
1984 9
1985 6
1986 3
1987 12
1988 11
1989 8
1990 6
1991 1
1992 3
1993 4
1994 11
1995 6
1996 4
1997 5
1998 9
1999 10
2000 9
2001 9
2002 10
2003 10
2004 15
2005 17
2006 20
2007 11
2008 18
2009 21
2010 22
2011 25
2012 28
2013 38
2014 45
2015 43
2016 46
2017 41
2018 50
2019 44
2020 48
2021 56
2022 36
2023 46
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

812 results

Results by year

Filters applied: . Clear all
Page 1
Akaluc bioluminescence offers superior sensitivity to track in vivo dynamics of SARS-CoV-2 infection.
Tamura T, Ito H, Torii S, Wang L, Suzuki R, Tsujino S, Kamiyama A, Oda Y, Tsuda M, Morioka Y, Suzuki S, Shirakawa K, Sato K, Yoshimatsu K, Matsuura Y, Iwano S, Tanaka S, Fukuhara T. Tamura T, et al. Among authors: fukuhara t. iScience. 2024 Mar 29;27(5):109647. doi: 10.1016/j.isci.2024.109647. eCollection 2024 May 17. iScience. 2024. PMID: 38638572 Free PMC article.
Neutralizing immunity against coronaviruses in Tanzanian health care workers.
Barabona G, Ngare I, Kamori D, Nkinda L, Kosugi Y, Mawazo A, Ekwabi R, Kinasa G, Chuwa H; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sato K, Sunguya B, Ueno T. Barabona G, et al. Sci Rep. 2024 Mar 6;14(1):5508. doi: 10.1038/s41598-024-55989-4. Sci Rep. 2024. PMID: 38448564 Free PMC article.
Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine.
Aboshi M, Matsuda K, Kawakami D, Kono K, Kazami Y, Sekida T, Komori M, Morey AL, Suga S, Smith JF, Fukuhara T, Iwatani Y, Yamamoto T, Sato N, Akahata W. Aboshi M, et al. Among authors: fukuhara t. iScience. 2024 Jan 22;27(2):108964. doi: 10.1016/j.isci.2024.108964. eCollection 2024 Feb 16. iScience. 2024. PMID: 38352232 Free PMC article.
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant.
Tamura T, Irie T, Deguchi S, Yajima H, Tsuda M, Nasser H, Mizuma K, Plianchaisuk A, Suzuki S, Uriu K, Begum MM, Shimizu R, Jonathan M, Suzuki R, Kondo T, Ito H, Kamiyama A, Yoshimatsu K, Shofa M, Hashimoto R, Anraku Y, Kimura KT, Kita S, Sasaki J, Sasaki-Tabata K, Maenaka K, Nao N, Wang L, Oda Y; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ikeda T, Saito A, Matsuno K, Ito J, Tanaka S, Sato K, Hashiguchi T, Takayama K, Fukuhara T. Tamura T, et al. Among authors: fukuhara t. Nat Commun. 2024 Feb 8;15(1):1176. doi: 10.1038/s41467-024-45274-3. Nat Commun. 2024. PMID: 38332154 Free PMC article.
Virological characteristics of the SARS-CoV-2 BA.2.86 variant.
Tamura T, Mizuma K, Nasser H, Deguchi S, Padilla-Blanco M, Oda Y, Uriu K, Tolentino JEM, Tsujino S, Suzuki R, Kojima I, Nao N, Shimizu R, Wang L, Tsuda M, Jonathan M, Kosugi Y, Guo Z, Hinay AA Jr, Putri O, Kim Y, Tanaka YL, Asakura H, Nagashima M, Sadamasu K, Yoshimura K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Saito A, Ito J, Irie T, Tanaka S, Zahradnik J, Ikeda T, Takayama K, Matsuno K, Fukuhara T, Sato K. Tamura T, et al. Among authors: fukuhara t. Cell Host Microbe. 2024 Feb 14;32(2):170-180.e12. doi: 10.1016/j.chom.2024.01.001. Epub 2024 Jan 26. Cell Host Microbe. 2024. PMID: 38280382 Free article.
First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.
Imai H, Kijima T, Azuma K, Kishi K, Saito H, Yamaguchi T, Tanizaki J, Yoneshima Y, Fujita K, Watanabe S, Kitazono S, Fukuhara T, Hataji O, Toi Y, Mizutani H, Hamakawa Y, Maemondo M, Ohsugi T, Suzuki K, Horinouchi H, Ohe Y. Imai H, et al. Among authors: fukuhara t. Jpn J Clin Oncol. 2024 Apr 6;54(4):452-462. doi: 10.1093/jjco/hyad195. Jpn J Clin Oncol. 2024. PMID: 38271158 Free PMC article.
812 results